Home > Back to Publisher > Report Information

Drug-Eluting Stents - Global Market Opportunities

BizAcumen, Inc.
November 1, 2009
130 Pages - SKU: BZAC2521973

Abstract Table of Contents Related Reports

Countries covered: Global

Increasing acceptance of stents as viable treatment option, expanding patient population seeking drug-eluting stents, and higher reimbursement coverage are key factors driving growth of drug-eluting stents. Development of innovative treatment methods and preventive measures for coronary diseases, obesity, and diabetes are few factors influencing the long-term growth prospects of the drug-eluting stents market.

Through registering significant growth in the recent past, incidents of adverse effects such as in-stent thrombosis is expected to significantly restrict future market growth. In-stent thrombosis is a common long-term adverse effect of DES where patients develop clots. Although in-stent thrombosis cases occur rarely, they are highly fatal. On the contrary, bare-metal stents do not pose such threats thereby augmenting its usage in interventional management. The rise in in-stent thrombosis cases paves the way for anti-thrombotic therapies. Moreover, drug-eluting stents faces stiff competition from advanced and safer technologies such as tiny wire mesh tubes.

These and other market data and trends are presented in "Drug-Eluting Stents: Global Market Opportunities" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. MARKET OVERVIEW: Current and Future Analysis; Major Issues and Trends
3. PRODUCT FACTS: Major Drug-Eluting Stent Products in the Market
4. COMPETITIVE SCENARIO: Drug-Eluting Stents-Competitive Arena
5. REGULATORY ENVIRONMENT: FDA Framework
6. CORPORATE DEVELOPMENTS: MIV Therapeutics Acquires Biosync Scientific; J & J Acquires Conor Medsystems; Lombard Collaborates With S&N; India Establishes Asia’s first Catheter and Stent Unit; Abbott Requests FDA Approval for Xience; Brookwood and TTV Start Joint Venture; SurModics Acquires Brookwood Pharmaceuticals, Inc; ARIAD Collaborates with ICON Medical; Biosensors Acquires 50% Stake in JWMS; Boston Completes European and Intercontinental Enrollment Phases; FDA Approves Boston Scientifis’s Taxus Stent with Extended Shelf Life; Abbott Launches Drug-Eluting Coronary Stent; Boston Introduces Taxus(R) Express2(TM) in Japan
7. MAJOR PLAYERS: Abbott Vascular (USA); Angiotech Pharmaceuticals, Inc (Canada); AngioDynamics® Inc. (USA); Boston Scientific, Inc. (USA); Biocompatibles International Plc (UK); Biosensors International Pte Ltd. (Singapore); Cordis Corporation (USA); Implant Sciences Corporation (USA); Medtronic, Inc. (USA); MIV Therapeutics Inc (Canada); SurModics, Inc. (USA)
8. GLOBAL MARKET ANALYTICS
9. THE UNITED STATES: Issues and Trends; Regulatory Environment
10. JAPAN: Healthcare System in Japan
11. EUROPE: a.France; b.Germany; c.Italy; d.The United Kingdom; e.Spain; f.Rest of Europe
12. REST OF WORLD
EXHIBITS: Table 1: Percentage Breakdown of Leading Drug Eluting Stents Brands in the World-2006; Table 2: Percentage Breakdown of Leading Players in the Global Drug Eluting Stents Market -2008; Table 3: Global Drug-Eluting Stents Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 4: Percentage Breakdown of Global Drug-Eluting Stents Market by Region for the Years 2008 & 2012; Table 5: Percentage Breakdown of Major Players in the US Market for Drug Eluting Stents - 2008; Table 6: Drug-Eluting Stents Market in the US: 2007-2015 (Sales in US$ Million); Table 7: Percentage Breakdown of Major Players in the Japanese Market for Drug Eluting Stents -2008; Table 8: Drug-Eluting Stents Market in Japan: 2007-2015 (Sales in US$ Million); Table 9: Percentage Breakdown of Major Players in the European Market for Drug Eluting Stents -2008; Table 10: Drug-Eluting Stents Market by Region in Europe: 2007-2015 (Sales in US$ Million); Table 11: Percentage Breakdown of Drug-Eluting Stents Market by Region in Europe for the Years 2008 & 2012; Table 12: Drug-Eluting Stents Market in France: 2007-2015 (Sales in US$ Million); Table 13: Drug-Eluting Stents Market in Germany: 2007-2015 (Sales in US$ Million); Table 14: Drug-Eluting Stents Market in Italy: 2007-2015 (Sales in US$ Million); Table 15: Drug-Eluting Stents Market in the UK: 2007-2015 (Sales in US$ Million); Table 16: Drug-Eluting Stents Market in Spain: 2007-2015 (Sales in US$ Million); Table 17: Drug-Eluting Stents Market in Rest of Europe: 2007-2015 (Sales in US$ Million); Table 18: Drug-Eluting Stents Market in Rest of World: 2007-2015 (Sales in US$ Million)
COMPANIES PROFILED

More Global Stents Reports

Peripheral Vascular & Interventional Cardiology Devices Market (2011 – 2016) (Balloons, Evar Stent Grafts, Ivc Filter, Ivus & Angiography Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Accessory Devices) Global Trends & Comp by MarketsandMarkets
The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, ...

Global Markets for Coronary Stent Devices by BCC Research
The global market for coronary stent devices reached $7.1 billion in 2011. By 2016, it is expected that total market value will reach $10.6 billion, ...

Nanotechnology in Medical Applications: The Global Market by BCC Research
INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify ...

Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016) by Transparency Market Research
The coronary stents market has witnessed patterns of increasing market growth along with some declining phases in its course of span. The introduction of drug-eluting ...

Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 by GlobalData
Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Bare Metal Stents (BMS) - Global Pipeline Analysis, ...

See all reports like this >>

Drug-Eluting Stents - Global Market Opportunities

Share this report

Other tasks

Research Assistance

Related Markets

Stents Reports

Free Alert Me service